Keyphrases
Alzheimer's Disease
96%
Older Adults
67%
Cognitive Impairment
48%
Frontotemporal Dementia
48%
Vascular Cognitive Impairment
40%
Dementia
40%
Aging
38%
Cerebral Small Vessel Disease (cSVD)
34%
White Matter Hyperintensities
34%
Executive Function
33%
Frontotemporal Lobar Degeneration
29%
Cognitive Dementia
28%
Autosomal Dominant
28%
Cerebrospinal Fluid
28%
Neurodegenerative Diseases
27%
Extracellular Vesicles
26%
Mild Cognitive Impairment
22%
Plasma Exosomes
20%
Subcortical Infarcts
20%
Arteriopathy
20%
Leukoencephalopathy
20%
Brain Health
20%
Neurofilament Light (NF-L)
19%
Clinical Trials
19%
Exosomes
18%
Processing Speed
18%
Brain Function
18%
Gray Matter Volume
17%
White Matter Injury
16%
Vascular Contributions
16%
Normal Adults
16%
Temporal Lobe
16%
Episodic Memory
15%
Exosomal Protein
15%
Clinical Severity
15%
Healthy Adults
15%
Early Alzheimer's Disease
14%
Protein Level
14%
Interleukin-6
14%
Cognitive Aging
14%
Genetic Risk
14%
Cerebrovascular Disease
14%
L1 Cell Adhesion Molecule (L1CAM)
13%
Magnetic Resonance Imaging
13%
Brain Structure
13%
MiRNA Signature
13%
Physical Activity
13%
Small Interfering RNA (siRNA)
13%
Innate Inflammation
13%
Acute Ischemic Stroke
13%
Neuroscience
Blood Plasma
100%
Alzheimer's Disease
92%
Cognitive Disorders
62%
Cerebrovascular Disease
45%
Frontotemporal Dementia
41%
Cerebrovascular Accident
36%
Neurodegenerative Disorder
32%
Amyloid Protein
32%
Magnetic Resonance Imaging
32%
Gray Matter Volume
31%
Mild Cognitive Impairment
29%
Temporal Lobe
29%
Executive Function
29%
Chemokine
27%
In Vivo
24%
Vascular Disease
24%
Clinical Dementia Rating
24%
Interleukin 6
20%
Behavior (Neuroscience)
20%
Frontal Variant Frontotemporal Dementia
17%
Blood Brain Barrier
15%
Neurofilament Light Chain
14%
Magnetic Resonance Imaging
14%
Placental Growth Factor
14%
Brain Ischemia
14%
Episodic Memory
13%
Apolipoprotein E
13%
CADASIL
13%
Positron Emission Tomography
13%
Glial Fibrillary Acidic Protein
13%
Neurotrauma
13%
Traumatic Brain Injury
13%
Multiple Sclerosis
13%
Brain Function
13%
Brain Disease
13%
Gray Matter
13%
Cognitive Change
12%
Functional Connectivity
12%
Monocyte Chemotactic Protein 1
11%
CD8
11%
T Cell
11%
Cognitive Function
11%
Vascular Dementia
10%
Tumor Necrosis Factor Alpha
10%
Interleukin 10
10%
Neurodegeneration
9%
MicroRNA
8%
Magnetic Resonance Imaging of Brain
8%
Depressive Disorder
8%
Cellular Senescence
8%
Medicine and Dentistry
Alzheimer's Disease
50%
Biological Marker
46%
Cognitive Defect
41%
Exosome
33%
Cerebrovascular Disease
31%
Amyloid Protein
28%
Diseases
25%
Brain Function
20%
CADASIL Syndrome
17%
Magnetic Resonance Imaging
16%
Vascular Disease
16%
Clinical Trial
16%
Tau
14%
Cognition
14%
Apoplexy
14%
Cerebrospinal Fluid
14%
White Matter Injury
13%
Mediator
13%
Neurofilament
13%
Light Chain
13%
Cross Sectional Study
13%
Multiple Sclerosis
13%
Neurology
13%
Systolic Blood Pressure
13%
Frontotemporal Lobar Degeneration
12%
Diagnosis
11%
Degenerative Disease
11%
Intervention Trial
10%
Blood Pressure
10%
Vascularity
9%
Immunity
9%
Small Vessel Disease
9%
Health Care Cost
8%
White Matter Disease
8%
Chemokine
8%
Blood Brain Barrier
8%
Cytokine
8%
Frontal Variant Frontotemporal Dementia
8%
Cognitive Change
8%
Cellular Senescence
7%
Interstitial Fluid
7%
Positron Emission Tomography
7%
Mild Cognitive Impairment
7%
Community-Dwelling Older Adults
6%
Clinical Endpoint
6%
Temporal Lobe
6%
Interleukin 18
6%
Insulin Resistance
6%
Instrumental Variable Analysis
6%
Disease Marker
6%